ArticleReumatologia2025
Evaluation of remission in patients with radiographic axial spondyloarthritis using an ultrasonography-based enthesitis score: a cross-sectional study.
Article in Reumatologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aimed to evaluate ultrasonographic entheseal abnormalities in patients with radiographic axial spondyloarthritis (r-axSpA) who were in clinical remission for at least 6 months and receiving either nonsteroidal anti-inflammatory drugs (NSAIDs) or biologic agents. Material and methods: Seventy-two r-axSpA patients were included, divided into NSAID users ( Results: A total of 720 entheseal sites were analyzed. The quadriceps tendon was the most frequently affected site (98.6%), followed by the distal patellar tendon (94.4%), Achilles tendon (70.8%), and plantar fascia (70.8%). Hypoechogenicity, thickening, enthesophyte formation, and bone erosion were the most common abnormalities, while PD signals and calcifications were rare. Nonsteroidal anti-inflammatory drug users showed significantly higher C-reactive protein (CRP) (0.62 ±0.53 vs. 0.41 ±0.27 mg/dl, Conclusions: Ultrasound-based enthesitis scoring may reveal subclinical disease activity in r-axSpA patients in remission, highlighting the added value of integrating musculoskeletal US into disease monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.